We evaluated the in vitro availability and its stability under simulated tropical conditions of variousformulations of four essential drugs marketed in Tanzania. We obtained 22 formulations (containingparacetamol, acetylsalicylic acid, chloroquine or sulphadoxine/pyrimethamine) from wholesalepharmacies in Dar es Salaam and the Medical Stores Department (Tanzania). The drug content, in vitroavailability (dissolution) and its stability under simulated tropical conditions were determined usingmethods specified in the United States Pharmacopoeia (USP) 24 monograph of the respective drugs. Allformulations passed the pharmacopoeia requirements for the drug content. However, sevenformulations (three acetylsalicylic acid, two sulphadoxine/pyrimethamine and two paracetamol) failedto meet the USP 24 tolerance limits for dissolution. Another five formulations (three paracetamol andtwo chloroquine) failed to meet the dissolution tolerance limits after being subjected to an acceleratedstability test under simulated tropical conditions (75% RH/40 ?C) for 6 months. The study hasdemonstrated the presence on the Tanzanian market of essential drug formulations that met potencyrequirements and yet had unsatisfactory in vitro availability as they were not robust enough to withstandstorage under simulated tropical conditions.